Curie Therapeutics is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Our mission at Curie is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.
Location: United States, Massachusetts, Woburn
Member count: 11-50
Total raised: $75M
Investors 2
| Date | Name | Website |
| 05.12.2021 | RA Capital... | racap.com |
| 04.12.2021 | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.12.2021 | Series A | $75M | - | marketscre... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 02.12.2021 | VC Daily: ... | Good day. Curie Therapeutics I... | - | - | wsj.com/ar... |
| 02.12.2021 | VC Daily: ... | - | - | - | wsj.com/ar... |
| 01.12.2021 | Curie Ther... | CAMBRIDGE, Mass., Dec. 1, 2021... | - | - | marketscre... |
| 01.12.2021 | Curie Ther... | CAMBRIDGE, MA, Curie Therape... | - | - | vcnewsdail... |
| 01.12.2021 | The future... | This is the web version of Ter... | - | - | fortune.co... |